Biolink Limited

POWER SEARCH PRICING

SOLUTIONS

biolink limited Company Information

Company Number

05881805

Next Accounts

Sep 2025

Directors

Juan Gonzalez-Blanco

Anthony Risino

View All

Shareholders

antec international limited

Group Structure

View All

Industry

Wholesale of chemical products

Registered Address

accounts department tenax road, trafford park, manchester, M17 1WT

Website

www.biolinklimited.co.uk

biolink limited Estimated Valuation

£7.6m

Pomanda estimates the enterprise value of BIOLINK LIMITED at £7.6m based on Net Assets of £3.5m and 2.19x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Biolink Limited is a live company located in manchester, M17 1WT with a Companies House number of 05881805. It operates in the wholesale of chemical products sector, SIC Code 46750. Founded in July 2006, it's largest shareholder is antec international limited with a 100% stake. Biolink Limited is a established, small sized company, Pomanda has estimated its turnover at £3.7m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Biolink Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating2.5out of 5

1 Strong

4 Regular

7 Weak

Size

annual sales of £3.7m, make it smaller than the average company (£21.5m)

Growth

3 year (CAGR) sales growth of -17%, show it is growing at a slower rate (7.5%)

EXPORT

Biolink Limited's latest turnover from December 2023 is estimated at £3.7 million and the company has net assets of £3.5 million. According to their latest financial statements, Biolink Limited has 10 employees and maintains cash reserves of £38.2 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Feb 2011	Mar 2010
Turnover	3,746,671	4,946,089	5,733,384	6,440,068	7,244,417	7,024,448	4,773,744	4,776,183	4,369,914	2,267,847	2,749,711	3,478,925	3,740,711	2,055,115	1,798,398
Other Income Or Grants
Cost Of Sales	2,975,556	3,989,563	4,599,247	5,209,372	5,934,152	5,826,787	3,920,056	3,827,453	3,470,518	1,835,005	2,245,303	2,815,227	3,056,178	1,653,498	1,422,519
Gross Profit	771,115	956,527	1,134,136	1,230,697	1,310,266	1,197,661	853,688	948,730	899,397	432,842	504,408	663,698	684,533	401,616	375,879
Admin Expenses	579,084	1,146,094	1,323,499	651,462	-1,216,134	487,187	676,854	781,336	841,464	384,308	288,010	534,370	692,198	326,242	375,148
Operating Profit	192,031	-189,567	-189,363	579,235	2,526,400	710,474	176,834	167,394	57,933	48,534	216,398	129,328	-7,665	75,374	731
Interest Payable					10,568	22,570	22,371	22,984	25,121	25,949	13,174
Interest Receivable	2,407	10,046	2,847	1,716	6,911	1,287	644	368	513	226	131	120	23	46	24
Pre-Tax Profit	194,437	-179,521	-186,516	580,951	2,522,743	689,191	155,107	144,778	33,325	22,811	203,355	129,447	-7,642	75,421	756
Tax	-48,609			-110,381	-479,321	-130,946	-29,470	-28,955	-6,665	-4,790	-46,772	-31,067		-21,118	-212
Profit After Tax	145,828	-179,521	-186,516	470,570	2,043,422	558,245	125,637	115,822	26,660	18,021	156,583	98,380	-7,642	54,303	544
Dividends Paid
Retained Profit	145,828	-179,521	-186,516	470,570	2,043,422	558,245	125,637	115,822	26,660	18,021	156,583	98,380	-7,642	54,303	544
Employee Costs	630,987	1,036,033	1,384,712	1,272,714	1,278,237	1,007,467	1,046,000	1,225,624	1,262,605	147,193	187,464	230,227	234,326	186,425	186,550
Number Of Employees	10	16	23	22	22	18	20	24	25	3	4	5	5	4	4
EBITDA*	332,917	-55,202	-61,211	704,247	2,607,666	742,223	236,953	222,610	118,339	91,847	228,145	142,071	4,080	82,199	731

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Feb 2011	Mar 2010
Tangible Assets	768,618	917,432	1,101,869	1,140,408	1,189,013	392,499	572,833	563,584	544,179	544,522	567,627	35,054	37,145	31,796	15,773
Intangible Assets	115,439	145,360	183,358	180,584	202,462	180,280	155,727	86,145	36,417	18,896	21,409	18,804	11,184	10,924
Investments & Other									100	201	201	201	201	201	201
Debtors (Due After 1 year)
Total Fixed Assets	884,057	1,062,792	1,285,227	1,320,992	1,391,475	572,779	728,560	649,729	580,696	563,619	589,237	54,059	48,530	42,921	15,974
Stock & work in progress	546,027	666,832	542,900	574,768	420,961	477,375	345,577	255,239	292,208	296,904	224,174	90,024	97,314	109,103	103,395
Trade Debtors	552,287	744,752	601,936	970,828	1,115,658	936,886	659,839	633,779	489,299	429,560	417,553	614,534	660,571	358,902	318,178
Group Debtors	2,775,208	1,644,723	1,399,063
Misc Debtors	15,112	17,564	42,954	30,111	31,478	1,615,277	15,628	8,619	20,085	3,894
Cash	38,156	53,525	520,515	1,757,191	1,674,283	168,765	83,161	174,564	119,636	85,419	5,015	47,480	429	8,803	9,752
misc current assets			13,674
total current assets	3,926,790	3,127,396	3,121,042	3,332,898	3,242,380	3,198,303	1,104,205	1,072,201	921,228	815,777	646,742	752,038	758,314	476,808	431,325
total assets	4,810,847	4,190,188	4,406,269	4,653,890	4,633,855	3,771,082	1,832,765	1,721,930	1,501,924	1,379,396	1,235,979	806,097	806,844	519,729	447,299
Bank overdraft							25,914	22,458	21,489
Bank loan						24,323				22,254
Trade Creditors	110,426	42,359	371,131	322,934	534,534	927,098	355,478	364,569	364,367	257,207	517,162	655,583	752,807	425,744	408,234
Group/Directors Accounts	56,569	194,367	262,166							5,087
other short term finances
hp & lease commitments
other current liabilities	330,029	348,874	25,398	419,620	550,801	569,244	196,340	222,925	139,975	151,820
total current liabilities	497,024	585,600	658,695	742,554	1,085,335	1,520,665	577,732	609,952	525,831	436,368	517,162	655,583	752,807	425,744	408,234
loans						288,807	306,823	333,146	358,397	370,812	405,360
hp & lease commitments
Accruals and Deferred Income
other liabilities					122,380	755,193	183,084	139,792	100,412	83,000			2,934	35,000	35,000
provisions	839,454	276,047	239,512	216,758	202,132	25,831	17,148	16,699	10,765	9,357	10,999	4,639	3,608	3,848	3,231
total long term liabilities	839,454	276,047	239,512	216,758	324,512	1,069,831	507,055	489,637	469,574	463,169	416,359	4,639	6,542	38,848	38,231
total liabilities	1,336,478	861,647	898,207	959,312	1,409,847	2,590,496	1,084,787	1,099,589	995,405	899,537	933,521	660,222	759,349	464,592	446,465
net assets	3,474,369	3,328,541	3,508,062	3,694,578	3,224,008	1,180,586	747,978	622,341	506,519	479,859	302,458	145,875	47,495	55,137	834
total shareholders funds	3,474,369	3,328,541	3,508,062	3,694,578	3,224,008	1,180,586	747,978	622,341	506,519	479,859	302,458	145,875	47,495	55,137	834

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Feb 2011	Mar 2010
Operating Activities
Operating Profit	192,031	-189,567	-189,363	579,235	2,526,400	710,474	176,834	167,394	57,933	48,534	216,398	129,328	-7,665	75,374	731
Depreciation	110,965	104,307	98,215	96,997	56,004	16,612	46,395	47,599	37,971	40,646	9,093	11,501	10,520	6,825
Amortisation	29,921	30,058	29,937	28,015	25,262	15,137	13,724	7,617	22,435	2,667	2,654	1,242	1,225
Tax	-48,609			-110,381	-479,321	-130,946	-29,470	-28,955	-6,665	-4,790	-46,772	-31,067		-21,118	-212
Stock	-120,805	123,932	-31,868	153,807	-56,414	222,136	90,338	-36,969	-4,696	72,730	134,150	-7,290	-11,789	5,708	103,395
Debtors	935,568	363,086	1,043,014	-146,197	-1,405,027	1,909,765	33,069	133,014	75,930	15,901	-196,981	-46,037	301,669	40,724	318,178
Creditors	68,067	-328,772	48,197	-211,600	-392,564	562,529	-9,091	202	107,160	-259,955	-138,421	-97,224	327,063	17,510	408,234
Accruals and Deferred Income	-18,845	323,476	-394,222	-131,181	-18,443	346,319	-26,585	82,950	-11,845	151,820
Deferred Taxes & Provisions	563,407	36,535	22,754	14,626	176,301	9,132	449	5,934	1,408	-1,642	6,360	1,031	-240	617	3,231
Cash flow from operations	82,174	-510,981	-1,395,628	258,101	3,355,080	-602,644	48,849	186,696	137,163	-111,351	112,143	68,138	41,023	32,776	-9,589
Investing Activities
capital expenditure	37,849	88,070	-92,387	-54,529	-899,962	45,201	-138,950	-124,349	-77,584	-17,695	-546,925	-18,272	-17,354	-33,772	-15,773
Change in Investments								-100	-101						201
cash flow from investments	37,849	88,070	-92,387	-54,529	-899,962	45,201	-138,950	-124,249	-77,483	-17,695	-546,925	-18,272	-17,354	-33,772	-15,974
Financing Activities
Bank loans					-24,323	24,323			-22,254	22,254
Group/Directors Accounts	-137,798	-67,799	262,166						-5,087	5,087
Other Short Term Loans
Long term loans					-288,807	-44,339	-26,323	-25,251	-12,415	-34,548	405,360
Hire Purchase and Lease Commitments
other long term liabilities				-122,380	-632,813	615,401	43,292	39,380	17,412	83,000		-2,934	-32,066		35,000
share issue										159,380					290
interest	2,407	10,046	2,847	1,716	-3,657	-21,283	-21,727	-22,616	-24,608	-25,723	-13,043	120	23	46	24
cash flow from financing	-135,391	-57,753	265,013	-120,664	-949,600	574,102	-4,758	-8,487	-46,952	209,450	392,317	-2,814	-32,043	46	35,314
cash and cash equivalents
cash	-15,369	-466,990	-1,236,676	82,908	1,505,518	-5,799	-91,403	54,928	34,217	80,404	-42,465	47,051	-8,374	-949	9,752
overdraft						-22,458	3,456	969	21,489
change in cash	-15,369	-466,990	-1,236,676	82,908	1,505,518	16,659	-94,859	53,959	12,728	80,404	-42,465	47,051	-8,374	-949	9,752

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for biolink limited. Get real-time insights into biolink limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for biolink limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in M17 area or any other competitors across 12 key performance metrics.

BIOLINK LIMITED group structure

Biolink Limited has no subsidiary companies.

Ultimate parent company

LANXESS AG

#0064036

ANTEC INTERNATIONAL LIMITED

00690279

2 parents

BIOLINK LIMITED

05881805

BIOLINK LIMITED Shareholders

antec international limited

100%

Biolink Limited currently has 3 directors. The longest serving directors include Dr Juan Gonzalez-Blanco (Apr 2021) and Mr Anthony Risino (Apr 2021).

officer	country	age	start	end	role
Dr Juan Gonzalez-Blanco	Germany	59 years	Apr 2021	-	Director
Mr Anthony Risino	England	56 years	Apr 2021	-	Director
Mr Steven Thompson		61 years	Nov 2021	-	Director

P&L

December 2023

turnover

3.7m

-24%

operating profit

192k

gross margin

20.6%

+6.42%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

3.5m

+0.04%

total assets

4.8m

+0.15%

cash

38.2k

-0.29%

net assets

Total assets minus all liabilities

Similar Companies

Similar companies unavailable for this selection

company number

05881805

Type

Private limited with Share Capital

industry

46750 - Wholesale of chemical products

incorporation date

July 2006

ultimate parent company

LANXESS AG

previous names

N/A

address

accounts department tenax road, trafford park, manchester, M17 1WT

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 7 charges/mortgages relating to biolink limited. Currently there are 4 open charges and 3 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for BIOLINK LIMITED. This can take several minutes, an email will notify you when this has completed.

biolink limited Company Information

biolink limited Estimated Valuation

biolink limited Estimated Valuation

biolink limited Estimated Valuation

Biolink Limited Overview

Biolink Limited Health Check

BIOLINK LIMITED financials

biolink limited Credit Report and Business Information

Biolink Limited Competitor Analysis

biolink limited Ownership

biolink limited directors

biolink limited company details

biolink limited Charges & Mortgages

biolink limited Capital Raised & Share Issues BETA

biolink limited Companies House Filings - See Documents